Genentech, Inc. is a biotechnology company that discovers, develops, manufactures and commercializes biotherapeutics for significant unmet medical needs. Sixteen of the approved biotechnology products originated from or are based on Genentech science. The Company manufactures and commercializes 11 biotechnology products in the United States.

 
 

Number of Employees

5,252  

Fiscal Year Ending Date

12/31/02  

Sales (in millions)

$2,719.25  

1-Yr. Sales Change

22.92% 

 

Stock Data

Market Capitalization (in millions)

43,828.38  

Percent Owned by Institutions

37.29% 

Shares Outstanding (in millions)

523.20  

Number of Institutional Shareholders

1,179  

Public Float (in millions)*

204.50  

Percent Owned by Insiders

60.91% 

Latest Dividend

n.a.    

Last Stock Split

2 for 1  

Date of Last Dividend

n.a.    

Date of Last Split

10/25/00  

Dividend Yield

n.a.    

P/E Ratio
(without extraordinary items)

76.16  

 

P/E Ratio
(with extraordinary items)

82.94  

*Shares outstanding, minus shares controlled by insiders, restricted stock and shares held by 5% owners

 

Short Interest

Total for current month

8,816,000  

Short Interest Ratio**

2.81  

Total for previous month

10,428,000  

Short Interest as % of Public Float

4.31